Argenx SE Files October 2025 6-K Report

Ticker: ARGX · Form: 6-K · Filed: Oct 15, 2025 · CIK: 1697862

Sentiment: neutral

Topics: 6-K, regulatory-filing, foreign-private-issuer

Related Tickers: ARGX

TL;DR

Argenx SE (ARGX) filed a 6-K on 10/15/25. Standard update.

AI Summary

Argenx SE filed a Form 6-K on October 15, 2025, reporting information for the month of October 2025. The filing is from their principal executive offices located in Amsterdam, the Netherlands. Argenx SE is a company focused on biological products.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding Argenx SE's ongoing operations and compliance as a foreign private issuer.

Risk Assessment

Risk Level: low — This filing is a routine report (6-K) and does not contain significant new financial or strategic information that would inherently increase risk.

Key Players & Entities

FAQ

What type of report is this filing?

This filing is a Form 6-K, a Report of Foreign Private Issuer.

Who is the filer of this report?

The filer is ARGENX SE.

What is the SEC file number for ARGENX SE?

The SEC file number is 001-38097.

What is the principal executive office address for ARGENX SE?

The principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.

What is the SIC code for ARGENX SE?

The Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).

Filing Stats: 284 words · 1 min read · ~1 pages · Grade level 14.3 · Accepted 2025-10-15 06:05:13

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: October 15, 2025 By: /s/ Hemamalini (Malini) Moorthy Name: Hemamalini (Malini) Moorthy Title: General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing